top of page

Large real-world study identifies distinct Type 2 inflammatory profile in COPD compared with asthma

Nov 3
2 min read

New research highlights important biological differences while reinforcing the role of blood eosinophils as a marker of type 2 inflammation


A large real-world study has found that people with chronic obstructive pulmonary disease (COPD) experience a range of type 2 (T2) inflammatory diseases traditionally associated with asthma, but these conditions occur less frequently than in asthma, even among patients with elevated blood eosinophil counts.


Published in ERJ Open Research, the study, titled ' Prevalence of type 2 multimorbidities in COPD compared to asthma and relationship to blood eosinophilic counts', analysed electronic health records from the UK Optimum Patient Care Research Database (OPCRD), including 122,509 people with COPD and 1,154,094 people with asthma, making it one of the largest studies to investigate type 2 inflammatory multimorbidities across these respiratory diseases.


T2 inflammation is a type of immune response involved in several allergic and inflammatory diseases. Researchers examined the prevalence of several T2 inflammatory multimorbidities (including allergic rhinitis, atopic dermatitis [eczema], nasal polyps, chronic rhinitis, eosinophilic esophagitis and ulcerative colitis) and their relationship to blood eosinophil counts (BEC), a marker of type 2 inflammation.


The study found that:

  • Type 2 inflammatory multimorbidities were present in both COPD and asthma.

  • Prevalence increased with higher blood eosinophil counts in both diseases.

  • After accounting for differences in age, sex, smoking history and other clinical factors, most type 2 multimorbidities remained significantly less common in COPD than in asthma.

  • Allergic rhinitis and nasal polyps showed the largest differences in prevalence between COPD and asthma, suggesting important biological distinctions despite shared inflammatory pathways.



Figure 1: Adjusted prevalence ratios for type 2 inflammatory multimorbidities in people with COPD compared to asthma. CI : confidence interval; * Adjusted for age, sex, body mass index (BMI), ethnicity, smoking, blood eosinophil count.


The study supports the growing understanding that type 2 inflammation manifests differently across these diseases, reflecting distinct underlying mechanisms.


Professor David Halpin, the lead author, said  “Our findings demonstrate that higher eosinophil counts are associated with a greater burden of type 2 inflammatory disease in both COPD and asthma, although the relationship differs between the two conditions. Growing our understanding of these conditions could help improve patient phenotyping and support the development of more personalised treatment strategies for COPD”.


To learn more about the study, please read the full publication in ERJ Open Research, as well as the accompanying slide deck.


About OPC and OPCRD

Optimum Patient Care (OPC), founded in 2008 by Professor David Price as a social enterprise and guided by leading clinical and academic experts, supports more than 1100 practices across the United Kingdom and is one of the biggest primary care research networks in the world.


The Optimum Patient Care Research Database (OPCRD) is established and maintained by OPC. The anonymous electronic medical records and patient questionnaires collected within OPCRD provide an essential source of real-world data to promote evidence-based research and quality improvement. Learn more at https://opcrd.optimumpatientcare.org

Opri Logo White
An academic research institution striving to improve the lives of patients.
Company
Observational and Pragmatic Research Institute (registered in Singapore) 
Observational Pragmatic Research International (registered in England and Wales)
Contact Us
Email:
info@opri.sg 
Tel:
(+65) 3105 1489 
Address
thumbnail_IMS-white-ISO_9001_ISO_27001-removebg-preview.png

Certificate
No: 385342022

CDP_Discloser_2026.png
GBC Accreditation
2025 Ecovadis.png
Designer_edited.png
SME-Committed-Badge-2026.png
OPRI Singapore
22 SIN MING LANE #06-76, MIDVIEW CITY,(573969) 
OPRI UK
Warren House, Sankence, Aylsham, Norwich NR11 6UN
  • Instagram
  • Threads
  • LinkedIn
  • X
OPRI 2026 All Rights Reserved
bottom of page